Dr Markus Hamm, the former CEO of family-owned German hospital group Schoen-Kliniken, has a new role as group CEO of German ophthalmology group Ober Scharrer. What does this say about the company’s plans?
Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinics is considering a €1bn sale, according to reports. A sceptical market source agrees that is a "very high" asking price, which may be equivalent to 25-30x EBITDA.
A specialist developer is planning to turn an underground carpark under a central London park near Harley Street into a four-storey subterranean healthcare and wellness development. Provisional talks with private hospital and diagnostic operators have been held, while wellness and leisure operators could be housed under the same roof. HBI talks exclusively to the team at Reef Group and its partners about the plan to transform historic Cavendish Square.
Dutch and Nordic ambulatory clinic operator Bergman Clinics is likely to be put up for sale in the first quarter of this year, independent sources tell HBI.
HBI hears ophthalmic specialist SpaMedica, the largest UK NHS cataract surgery provider, is back up for sale just two months after it was pulled from the market. HBI speaks to a UK based market expert to find out more, and about how the group continues to carve out a growing niche for itself, and speculates on price and multiple.
The largest UK NHS cataract surgery provider, ophthalmic specialist SpaMedica, was pulled from sale recently after just a few weeks on the market and before bids could be submitted, HBI hears. But it could soon be back on the market, and HBI talks to three market experts to find out more about the aborted process, possible prices and suitors.
Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.
After 19 years as a health care services expert working as an investment banker, analyst and consultant, Martin Brunninger has returned to his native Austria to become director-general for healthcare and social care. In this role, he is responsible for reforming the entire health and social care system under the new reformist conservative coalition government which came to power in December 2017 and is likely to hold power for a few years. We talk to Brunninger about the likely changes and his change in role.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
